/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Aclaris Therapeutics

Aclaris Therapeutics

United States

Aclaris Therapeutics is a biopharmaceutical company that strives to translate scientific discovery into everyday victories in immuno-inflammatory conditions.

Healthcare & Biotech

Aclaris Therapeutics, based in United States, has 5 investors on file, among them Aisling Capital, Aperture Venture Partners and F-Prime Capital. Its site was last checked 6 Nov 2026: site answers.

aclaristx.com

SEC Form D filings

6 filings
$80.0M sold4 Dec 2024$11.0M sold of $11.4M offered8 Apr 2020$10.0M sold of $12.5M offered13 Aug 2018$10.0M sold of $12.5M offered14 Aug 2017$20.0M sold14 Jun 2016$40.0M sold11 Sept 2015

Filed by Aclaris Therapeutics, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.

Investors

5 investors on file
InvestorEvidenceType
Aisling CapitalPortfolio pageVenture capital
Aperture Venture PartnersPortfolio pageVenture capital
F-Prime CapitalPortfolio pageVenture capital
Foresite CapitalPortfolio pageVenture capital
RA CapitalPortfolio pageVenture capital

In the news

2 headlines naming Aclaris Therapeutics
Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conferencemanilatimes.netAclaris Therapeutics (NASDAQ:ACRS) Issues Quarterly Earnings Resultstickerreport.com

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Aclaris Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Aisling Capital adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/aclaristx.com/investors

# also
GET /v1/companies/aclaristx.com
GET /v1/companies/aclaristx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing